MA28849B1 - Procede pour la preparation d'un piroxicame : compose d'inclusion a base de beta-cyclodextrine - Google Patents

Procede pour la preparation d'un piroxicame : compose d'inclusion a base de beta-cyclodextrine

Info

Publication number
MA28849B1
MA28849B1 MA29734A MA29734A MA28849B1 MA 28849 B1 MA28849 B1 MA 28849B1 MA 29734 A MA29734 A MA 29734A MA 29734 A MA29734 A MA 29734A MA 28849 B1 MA28849 B1 MA 28849B1
Authority
MA
Morocco
Prior art keywords
piroxicam
cyclodextrin
beta
preparation
inclusion compound
Prior art date
Application number
MA29734A
Other languages
English (en)
Inventor
Roberto Pighi
Andersen Soeren Fjordgaard
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA28849B1 publication Critical patent/MA28849B1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA29734A 2004-08-02 2007-03-02 Procede pour la preparation d'un piroxicame : compose d'inclusion a base de beta-cyclodextrine MA28849B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04018261 2004-08-02

Publications (1)

Publication Number Publication Date
MA28849B1 true MA28849B1 (fr) 2007-09-03

Family

ID=35502714

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29734A MA28849B1 (fr) 2004-08-02 2007-03-02 Procede pour la preparation d'un piroxicame : compose d'inclusion a base de beta-cyclodextrine

Country Status (17)

Country Link
US (1) US20090012284A1 (fr)
EP (1) EP1793862B1 (fr)
JP (1) JP2008508332A (fr)
KR (1) KR20070038109A (fr)
CN (1) CN101123989B (fr)
AT (1) ATE502653T1 (fr)
AU (1) AU2005268972A1 (fr)
DE (1) DE602005027092D1 (fr)
IL (1) IL181101A0 (fr)
MA (1) MA28849B1 (fr)
MX (1) MX2007001237A (fr)
NO (1) NO20070669L (fr)
PL (1) PL1793862T3 (fr)
PT (1) PT1793862E (fr)
TN (1) TNSN07012A1 (fr)
WO (1) WO2006013039A2 (fr)
ZA (1) ZA200700946B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101491529B (zh) * 2009-01-23 2011-04-06 上海微丸医药开发有限公司 一种吡罗昔康β-环糊精包合物微丸胶囊的制备方法
BR102012009317B1 (pt) * 2012-04-20 2022-05-31 Universidade Federal De Minas Gerais - Ufmg Processo de preparação de compostos de inclusão envolvendo ciclodextrinas e fármacos, usando um sistema de fluxo contínuo
WO2014161131A1 (fr) * 2013-04-01 2014-10-09 Arissa Pharma Préparation d'un complexe d'inclusion de méloxicam-β-cyclodextrine amorphe par l'intermédiaire d'un procédé de séchage par atomisation
ES2672472T3 (es) * 2013-12-12 2018-06-14 Synthon Bv Composición farmacéutica que comprende ivabradina amorfa
WO2016193096A1 (fr) * 2015-05-29 2016-12-08 Givaudan Sa Séchage par pulvérisation
US20170056253A1 (en) * 2015-08-28 2017-03-02 Fitesa Nonwoven, Inc. Absorbent Article Having A High Content Of Bio-Based Materials
LT3565602T (lt) * 2017-01-09 2021-06-25 SciPharm S.à r.l. Naujas būdas, skirtas vandenyje tirpaus forskolino paruošimui
JP2020533155A (ja) * 2017-09-21 2020-11-19 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 吸収性物品
CN110575550A (zh) * 2019-08-13 2019-12-17 大梆(沈阳)动物保健有限公司 一种遮蔽兽用复方中药不良嗅味的方法
CN112471565A (zh) * 2020-12-18 2021-03-12 鲁南制药集团股份有限公司 一种挥发油喷雾研磨包合设备

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
EP0687174B1 (fr) * 1993-03-05 2001-06-13 Hexal Ag Complexes cristallins d'insertion de cyclodextrine de l'hydrochlorure de ranitidine, et leur procede de preparation
KR20030041577A (ko) * 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
WO2006011044A1 (fr) * 2004-07-22 2006-02-02 Pfizer Products Inc. Compositions a base de cyclodextrine amorphe

Also Published As

Publication number Publication date
AU2005268972A1 (en) 2006-02-09
CN101123989B (zh) 2010-12-15
HK1116054A1 (en) 2008-12-19
TNSN07012A1 (en) 2008-06-02
NO20070669L (no) 2007-05-02
PL1793862T3 (pl) 2011-08-31
JP2008508332A (ja) 2008-03-21
US20090012284A1 (en) 2009-01-08
KR20070038109A (ko) 2007-04-09
ZA200700946B (en) 2008-06-25
MX2007001237A (es) 2007-04-18
EP1793862B1 (fr) 2011-03-23
PT1793862E (pt) 2011-04-08
DE602005027092D1 (de) 2011-05-05
ATE502653T1 (de) 2011-04-15
EP1793862A2 (fr) 2007-06-13
WO2006013039A2 (fr) 2006-02-09
IL181101A0 (en) 2007-07-04
WO2006013039A3 (fr) 2007-08-23
CN101123989A (zh) 2008-02-13

Similar Documents

Publication Publication Date Title
IL181101A0 (en) A process for the preparation of a piroxicam: betacyclodextrin inclusion compound
TW200519106A (en) Organic compounds
MY135050A (en) Organic compounds
HRP20050735A2 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
WO2008044243A3 (fr) Nouveau procédé de préparation de statines et leurs sels pharmaceutiquement acceptables
GB0719180D0 (en) New process
WO2008012542A8 (fr) Dérivatisation d'érythropoïétine
WO2004113330A8 (fr) Compositions et composes immunosuppresseurs
DE602005008065D1 (de) Von phosphatidylinosit-(pi-)3-kinase und deren verwendung bei der behandlung von krebs
WO2007131982A3 (fr) Prolinamides substitués, procédé de production et utilisation de ceux-ci comme médicaments
CY1107693T1 (el) Μεθοδος παρασκευης ενωσεων εγκλεισμου πιροξικαμησ:β-κυκλοδεξτρινης
WO2007015004A3 (fr) Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
MY144634A (en) 3-or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
WO2007015003A3 (fr) Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
EP1815746A4 (fr) Lait fermenté et procédé de synthèse dudit lait
WO2003004501A3 (fr) Composes therapeutiques
IL186513A0 (en) Aminoalkyl - amidomethyl - substituted 2 - (4 - sulphonylamino) - 3 - hydroxy - 3, 4 - dihydro - 2h - cromen - 6-yl derivatives and their use as potassium channel blockers
SG161207A1 (en) Compositions comprising an epothilone and production methods
FR2857026B1 (fr) Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
WO2006074919A3 (fr) Amides d'acide 3-amino-6-aryl-thieno[2,3-b]pyridine-2-carboxylique, preparations pharmaceutiques contenant ces composes et utilisation desdits composes comme inhibiteurs de la liberation de tnf$g(a)
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
WO2002087574A3 (fr) Utilisation de derives de pyridoindolone pour la preparation de medicaments anticancereux
WO2003004460A3 (fr) Derives d'acide succinique
WO2008102584A1 (fr) Nouveau composé de flavanol et son procédé de production